3 Best Value Stocks with Over 20% Upside to Buy, According to Analysts

Value stocks are shares of companies that appear undervalued relative to their fundamentals. This means their stock price looks low compared with what the business earns, owns, or is expected to generate in the future. They often come from mature, financially stable companies with steady cash flow, consistent profits, and strong balance sheets.

Claim 30% Off TipRanks Premium

• Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions

• Stay ahead of the market with the latest news and analysis and maximize your portfolio’s potential

Value stocks tend to have lower valuation ratios, such as low price‑to‑earnings (P/E) or price‑to‑book (P/B) ratios, suggesting the market may be underpricing the company.

Now, let’s check the three value stocks that analysts have spotlighted. Each offers more than 20% upside potential from current levels.

Here Are This Week’s Stocks

Tenet Healthcare THC -1.23% ▼ – This U.S. healthcare services company operates hospitals and outpatient centers. It has a Strong Buy analyst consensus rating and an average price target of $263.23, implying a 31.98% upside potential from the current levels. The company’s P/E of 12.83x reflects a 44.7% discount to the Healthcare sector’s median of 23.22.

Earlier this month, Guggenheim raised its price target on Tenet Healthcare to $283 from $271 while maintaining a Buy rating. The firm sees further upside ahead, citing an “easy set‑up” for Q1 and confidence that 2026’s roughly 10% core EBITDA growth is a manageable hurdle based on historical trends.

**PNC Financial **PNC +1.52% ▲ – This major U.S. bank provides retail and corporate banking, asset management, and financial services across the country. Its average price target of $257.46 implies a 24.48% upside potential from the current levels. PNC stock has a Strong Buy consensus rating. Trading at a P/E of 10.18x, the company is valued 16.8% below the Financial sector’s median multiple of 12.23.

Last month, JPMorgan’s Vivek Juneja raised PNC stock’s price target to $251 from $228.50 and kept an Overweight rating, citing supportive trends, steady fundamentals, and expectations for two rate cuts with long‑term rates staying sticky.

**Micron **MU -2.36% ▼  – This memory and storage chip maker benefits from rising demand for DRAM and NAND driven by AI, data centers, and high-performance computing. It has a Strong Buy analyst consensus rating and an average price target of $537.57, implying a 36.75% upside potential from the current levels. With a P/E ratio of 8.48x, the stock is priced at a 72.3% discount to the Technology sector’s median of 30.56.

Last week, Micron delivered blowout quarterly results with revenue nearly tripling and EPS surging. However, the stock slipped on profit‑taking and supply‑constraint concerns.

Disclaimer & DisclosureReport an Issue